Litcius/Paper detail

The role of tyrosine kinase inhibitors in the treatment of HER2+ metastatic breast cancer

Fanny Le Du, Véronique Dièras, Giuseppe Curigliano

2021European Journal of Cancer52 citationsDOI

Topics & Concepts

LapatinibMedicineNeratinibMetastatic breast cancerTrastuzumabAfatinibBreast cancerRashAdverse effectOncologyInternal medicineCancerEpidermal growth factor receptorErlotinibHER2/EGFR in Cancer ResearchChronic Lymphocytic Leukemia ResearchCancer Treatment and Pharmacology
The role of tyrosine kinase inhibitors in the treatment of HER2+ metastatic breast cancer | Litcius